Author Archives: Lu Rahman

#Clinical specialities #Metabolomics

Metabolomics: the science behind a Tour de France winner

A CU Anschutz research team, experts in athletes’ baseline metabolic profiles and how these physiologies change during competition, are helping guide some of the world’s elite athletes to their best performances, including the recent Tour de France winner. Their understanding of the metabolic underpinnings of top athletes has implications for… Read More

#News

#Cell therapy #Therapeutics

Catalent to acquire Bone Therapeutics’ cell therapy facility for €12 million

Bone Therapeutics, the cell therapy company and Catalent Pharma Solutions, provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies have announced the signing of share purchase and supply agreements. The agreements will streamline and economise the manufacturing operations of ALLOB, Bone Therapeutics’ allogeneic… Read More

#News

#Antibodies #Covid-19 #Novel candidates #Therapeutics

Novel COVID-19 antibody therapy candidates identified by UK biotech consortium

The UK BIA Antibody Taskforce, a UK consortium developing antibodies for treating COVID-19 has reached a major milestone – the identification of differentiated antibody combinations that will be taken forward for further development as an antibody ‘cocktail’. The Taskforce developed an accelerated and rigorous multifaceted approach to create a pool… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Drug development #Drug discovery #Oncology

New drug for difficult-to-drug cancer mutation could be key treatment for other cancers

A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows. Researchers used an innovative, intermittent treatment schedule to limit the drug’s toxicity, and… Read More

#Cancer Research #News #Trending News

#Drug development #Pharmacokinetics / Pharmacodynamics

TherapeutAix teams up with CROs to solve PK/PD challenges

Life sciences consultancy, TherapeutAix, has added contract research organisations (CROs), Alderley Analytical and Peak Proteins to its global R&D network, forming a dedicated and expert team to solve Pharmacokinetics and Pharmacodynamics (PK/PD) challenges faced by clients. Based in Aachen, Germany, TherapeutAix is a biotech consultancy providing services from strategic planning… Read More

#News

#AI / data analytics / healthtech / informatics

Collaboration creates voice-assisted lab workflows

Dotmatics has teamed up with LabVoice to provide R&D scientists with the ability to record, access, and track data within an electronic laboratory notebook (ELN) using hands-free voice assisted technology. The integration streamlines data capture into Dotmatics’ web-based ELN through LabVoice’s scientific virtual assistant, saving scientists’ time and improving overall… Read More

#News

#Enabling technologies #Events

Digital format proves success for Analytica 2020

A total of 21,641 participants from 152 nations took part in this key trade fair for laboratory technology, analysis and biotechnology from October 19 to 23. For the first time it was entirely virtual. 268 exhibitors from 24 countries presented more than 700 products. The event boasted 200 exhibitor webinars… Read More

#News

#Cell therapy #Gene therapy

Bayer acquires AskBio to broaden innovation in cell and gene therapy

Bayer has acquired Asklepios BioPharmaceutical (AskBio) a US-headquartered biopharmaceutical company specialising in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s development portfolio includes investigational pre-clinical and clinical stage candidates for the treatment of neuromuscular, central nervous system, cardiovascular and metabolic diseases. Bayer will own full… Read More

#News #Trending News

#ADME / Tox #Drug development

CN Bio to provide drug metabolism and safety toxicity testing services 

The 3D cell culture company, CN Bio, has launched Drug Metabolism and Safety Toxicity Testing Services. Liver toxicity is a principal safety concern during drug discovery and development, with the potential to terminate expensive clinical trials already underway. The new services will incorporate the company’s advanced Liver-on-Chip technology and expertise… Read More

#News

#Assay development & optimisation #Biomarkers #Diagnostics #In vitro

BioIVT to host emerging technologies in diagnostics symposium

BioIVT will be hosting a virtual Emerging Technologies in Diagnostics Symposium on  Thursday, October 29 (10am-1pm ET). “The diagnostic assay landscape is changing rapidly as the demand for faster, less expensive, more precise diagnostics continues to grow,” said Cathie Miller, Director of Product Marketing, Personalised Medicine at BioIVT. “We wanted… Read More

#News

#Bioproduction #Drug discovery

Testa Challenge 2020 attracts bioprocessing innovators

Six bioprocessing innovators have successfully completed the inaugural Testa Challenge 2020. Held over an intensive week in the Testa Center located at Cytiva´s Uppsala site, a biomanufacturing scale-up facility, the Testa Challenge aims to allow start-ups, research groups and companies from around the world to run and validate their innovative… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines

Moderna agreement to supply Qatar with mRNA COVID-19 vaccine

Moderna has announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273, Moderna’s vaccine candidate against COVID-19. “We appreciate the confidence of the Ministry of Health of Qatar in our mRNA vaccine platform and the collaboration we have had to date,” said Stéphane Bancel, Moderna’s Chief… Read More

#Covid-19 #News

#Covid-19 #Immunology / Virology & Vaccines

Oxford COVID-19 vaccine follows genetic instructions, analysis finds

The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) has been shown to work as planned. A team at Bristol University has used recently developed techniques to further validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team. This novel analysis… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Events #Ingredients / APIs / Fine chemicals

Chemspec Digital 2020: interactive networking for the chemicals community

Chemspec Digital 2020 will be hosted online from 11 – 12 November. The event will provide interactive networking for the fine and speciality chemicals community. From all over the world, industry experts will have the opportunity to meet, conduct business, discover innovative substances and learn about the latest trends &… Read More

#News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Global clinical trials of COVID-19 vaccine resume

The Food and Drug Administration (FDA) has today authorised a restart of clinical trials of the ChAdOx1 nCov-2019 Oxford coronavirus vaccine in the USA following the trials restarting in the UK, Brazil, South Africa and Japan. On 6 September, a standard review process triggered a voluntary pause to vaccination across… Read More

#Covid-19 #Editor's Choice #News